{"id":"NCT05681715","sponsor":"UCB Biopharma SRL","briefTitle":"A Phase 3, Open-label, Crossover Study to Evaluate Self-administration of Rozanolixizumab by Study Participants With Generalized Myasthenia Gravis (gMG)","officialTitle":"An Open-label, Crossover Study to Evaluate Rozanolixizumab Self-administration by Study Participants With Generalized Myasthenia Gravis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2023-04-17","primaryCompletion":"2024-04-23","completion":"2024-04-23","firstPosted":"2023-01-12","resultsPosted":"2025-05-07","lastUpdate":"2025-05-07"},"enrollment":62,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Generalized Myasthenia Gravis"],"interventions":[{"type":"DRUG","name":"Rozanolixizumab","otherNames":[]}],"arms":[{"label":"Rozanolixizumab Sequence 1: Syringe Driver - Manual Push","type":"EXPERIMENTAL"},{"label":"Rozanolixizumab Sequence 2: Manual Push - Syringe Driver","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to evaluate the ability of study participants with generalized Myasthenia Gravis (gMG) to successfully self-administer rozanolixizumab after training in the self-administration technique using the syringe driver and manual push methods.","primaryOutcome":{"measure":"Percentage of Participants With Successful Self-administration of Rozanolixizumab (With Correct Use of Syringe Driver and Manual Push, Respectively) During the Self-administration Period at Visit 13 (Week 12)","timeFrame":"Week 12 (last dose of Self-administration Period 1)","effectByArm":[{"arm":"Period 1: RLZ SRD","deltaMin":100,"sd":null},{"arm":"Period 1: RLZ MP","deltaMin":100,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":6},"locations":{"siteCount":27,"countries":["United States","Canada","Georgia","Germany","Italy","Japan","Poland","Serbia","Spain","United Kingdom"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":62},"commonTop":["Headache","Pyrexia","COVID-19","Diarrhoea","Nasopharyngitis"]}}